Personalis, Inc. (PSNL): Revenue

Annual figures by period end, from SEC filings.

$69.65M
Year ended 2025-12-31
$69.67M
Trailing 12 months to 2026-06-30
+2.3%
3-year compound annual growth
-2.4%
5-year compound annual growth
$85.49M2017-12-31: $9.39M2018-12-31: $37.77M2019-12-31: $65.21M2020-12-31: $78.65M2021-12-31: $85.49M2022-12-31: $65.05M2023-12-31: $73.48M2024-12-31: $84.61M2025-12-31: $69.65M$69.65M
2017-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$69.65M-17.7%2026-02-26, From 2025-01-01
2024-12-31$84.61M+15.2%2026-02-26, From 2024-01-01
2023-12-31$73.48M+13.0%2025-02-27, From 2023-01-01
2022-12-31$65.05M-23.9%2024-02-28, From 2022-01-01
2021-12-31$85.49M+8.7%2024-02-28, From 2021-01-01
2020-12-31$78.65M+20.6%2023-02-23, From 2020-01-01
2019-12-31$65.21M+72.6%2022-02-24, From 2019-01-01
2018-12-31$37.77M+302.2%2021-02-25, From 2018-01-01
2017-12-31$9.39Mn/a2020-03-25, From 2017-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Personalis, Inc. (PSNL)2025-12-31$69.65M-17.7%
Exagen Inc. (XGN)2025-12-31$66.58M+19.7%
Biodesix Inc (BDSX)2025-12-31$88.50M+24.1%
GRAIL, Inc. (GRAL)2025-12-31$147.17M+17.2%
CapForce Inc. (CFOR)2025-12-31$30.20M+481.2%
American Shared Hospital Services (AMS)2025-12-31$28.08M-0.9%
BillionToOne, Inc. (BLLN)2025-12-31$305.11M+100.0%
Fulgent Genetics, Inc. (FLGT)2025-12-31$322.67M+13.8%
Castle Biosciences Inc (CSTL)2025-12-31$344.23M+3.7%

Compare PSNL, XGN, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗